Yibin Wang

1.2k total citations · 2 hit papers
9 papers, 972 citations indexed

About

Yibin Wang is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Yibin Wang has authored 9 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Biomedical Engineering and 5 papers in Biomaterials. Recurrent topics in Yibin Wang's work include RNA Interference and Gene Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Yibin Wang is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Yibin Wang collaborates with scholars based in Australia, China and United States. Yibin Wang's co-authors include Meng Zheng, Bingyang Shi, Yan Zou, Dongya Zhang, Wei Tao, Jinlong Yin, Jia Li, Roger S. Chung, Jong Bae Park and Weimin Ruan and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Yibin Wang

9 papers receiving 963 citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy

2022 146 citations Yan Zou, Yibin Wang et al. Advanced Materials profile →
Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment

2023 116 citations Yan Zou, Yajing Sun et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yibin Wang Australia	8	544	428	341	128	83	9	972
Zhilan Chai China	15	572 1.1×	504 1.2×	560 1.6×	43 0.3×	73 0.9×	16	1.1k
Lingyan Lv China	16	362 0.7×	260 0.6×	347 1.0×	51 0.4×	59 0.7×	22	749
Mengyin Jiang China	11	499 0.9×	367 0.9×	563 1.7×	48 0.4×	67 0.8×	11	1.0k
Haojun Ma China	21	943 1.7×	517 1.2×	750 2.2×	99 0.8×	55 0.7×	28	1.6k
Deyu Miao China	9	443 0.8×	324 0.8×	481 1.4×	43 0.3×	51 0.6×	15	895
Achuthamangalam B. Madhankumar United States	13	345 0.6×	208 0.5×	206 0.6×	85 0.7×	114 1.4×	19	791
Yuyang Kuang China	18	1.0k 1.9×	501 1.2×	783 2.3×	93 0.7×	47 0.6×	21	1.6k
Xingye Feng China	10	378 0.7×	348 0.8×	407 1.2×	45 0.4×	56 0.7×	11	713
Liangcen Chen China	9	569 1.0×	454 1.1×	764 2.2×	55 0.4×	93 1.1×	9	1.1k
Pedro M. Costa United Kingdom	20	699 1.3×	427 1.0×	281 0.8×	271 2.1×	47 0.6×	29	1.3k

Countries citing papers authored by Yibin Wang

Since Specialization

Citations

This map shows the geographic impact of Yibin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibin Wang more than expected).

Fields of papers citing papers by Yibin Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibin Wang. The network helps show where Yibin Wang may publish in the future.

Co-authorship network of co-authors of Yibin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yibin Wang. A scholar is included among the top collaborators of Yibin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibin Wang. Yibin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Li, Shanshan, Dongya Zhang, Yibin Wang, et al.. (2025). Tumor cell-derived engineered exosome enhances effective immunotherapy for orthotopic glioblastoma and its recurrences. Nano Today. 63. 102748–102748. 3 indexed citations

2.

Zou, Yan, Yajing Sun, Yibin Wang, et al.. (2023). Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Nature Communications. 14(1). 4557–4557. 116 indexed citations breakdown →

3.

Ismail, Muhammad, Yanfei Li, Yibin Wang, et al.. (2022). Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition. Biomaterials. 289. 121760–121760. 42 indexed citations

4.

Zou, Yan, Yibin Wang, Sen Xu, et al.. (2022). Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy. Advanced Materials. 34(33). e2203958–e2203958. 146 indexed citations breakdown →

5.

Morsch, Marco, Muhammad Ismail, Yanjie Liu, et al.. (2022). Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy. ACS Nano. 16(4). 6293–6308. 83 indexed citations

6.

Wang, Yibin, Yajing Sun, Nan Geng, et al.. (2022). A Biomimetic Nanomedicine Targets Orthotopic Glioblastoma by Combinatorial Co‐Delivery of Temozolomide and a Methylguanine‐DNA Methyltransferase Inhibitor. Advanced Therapeutics. 5(12). 9 indexed citations

7.

Zou, Yan, Yibin Wang, Yanjie Liu, et al.. (2020). Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment. Advanced Materials. 32(24). e2000416–e2000416. 141 indexed citations

8.

Zhou, Yutong, Feiyan Zhu, Yang Liu, et al.. (2020). Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy. Science Advances. 6(41). 234 indexed citations

9.

Zheng, Meng, Yuanyuan Liu, Yibin Wang, et al.. (2019). ROS‐Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy. Advanced Materials. 31(37). e1903277–e1903277. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact